API & Intermediates

Your Trusted Partner in API and Intermediates Manufacturing

Maithili Life Sciences is a renowned name in the pharmaceutical industry, revered for its commitment to excellence in the manufacturing of Active Pharmaceutical Ingredients (APIs) and intermediates. As a leading API manufacturer in India, we pride ourselves on our ability to deliver high-quality, innovative products that cater to the evolving needs of the global healthcare market.

Our Commitment to Quality

At Maithili Life Sciences, quality is our cornerstone. Our meticulously manufactured APIs and Intermediates adhere to the highest international standards, ensuring the efficacy, safety, and reliability of the final pharmaceutical formulations. With a relentless commitment to quality control and regulatory compliance, we stand as your trusted partner in delivering pharmaceutical solutions that make a difference.

Comprehensive Portfolio of API and Intermediates

Dive into our comprehensive portfolio, meticulously crafted to meet the diverse needs of the pharmaceutical industry:

API Excellence

Our validated APIs, including Dabigatran Etexilate Mesylate, Pregabalin, Sumatriptan, and more, represent the pinnacle of pharmaceutical innovation. Rigorous testing and adherence to global pharmacopeias guarantee the highest quality standards.

Intermediates Expertise

Maithili Life Sciences excels in the production of intermediates critical to pharmaceutical synthesis. Our commitment to precision and consistency ensures seamless integration into your manufacturing processes.

Azilsartan Medoxomil Potassium Salt

&

Apply Now

Benazepril Hcl

&

Apply Now

Biperiden Hcl

&

Apply Now

Briveracetam (R&D)

&

Apply Now

Cabergoline

&

Apply Now

Darolutamide (R&D)

&

Apply Now

Dabigatran Etexilate Mesylate

&

Apply Now

Dapoxetine Hcl

&

Apply Now

Enclomiphene Citrate (R&D)

&

Apply Now

Favipiravir

&

Apply Now

Irbesartan

&

Apply Now

Minoxidil

&

Apply Now

Modafinil

&

Apply Now

Naftidrofuryl Oxalate

&

Apply Now

Nebivolol HCl

&

Apply Now

Ornidazole

&

Apply Now

Rasagiline Mesylate

&

Apply Now

Solifenacin Succinate

&

Apply Now

Sumatriptan Succinate

&

Apply Now

Tadalafil

&

Apply Now

Tamsulosin

&

Apply Now

Telmisartan

&

Apply Now

Torsemide

&

Apply Now

Trazodone Hcl

&

Apply Now

Ticagrelor

&

Apply Now

Vardenafil Hcl Trihydrate

&

Apply Now

Voriconazole

&

Apply Now

Zaltoprofen

&

Apply Now

	Key Intermediates	DMF Status	Filing
Azilsartan Medoxomil Potassium Salt	2-ethoxy-1-{[2'-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)-1,1'-biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylic acid, [147403-03-0], Azilsartan Base	DMF Available	KDMF Filing
Benazepril HCl	3-Bromo-2,3,4,5-tetrahydro-2-h-1-benzacepin-2one [86499-96-9], tert-Butyl (S)-2-(3-amino-2-oxo-2,3,4,5-tetrahydro-1H-benzo[b]azepin-1-yl)acetate [109010-60-8]
Brivaracetam	(R)-4-Propyldihydrofuran-2(3H)-one [63095-51-2]
Cabergoline Intermediates	Cabergoline Acid
Dabigatran Etexilate Mesylate	Ethyl 3-(3-amino-4-(methylamino)-N-(pyridin-2-yl)benzamido)propanoate [212322-56-0]	DMF Available	CEP Filing
Dapoxetine HCl	3-(Napthalen-1-yloxy)-1-phenylpropan-1-ol [908291-72-5], Dapoxetine Base [119356-77-3]	DMF Available
Darolutamide Intermediates	4-Bromo-2-Chlorobenzonitrile
Etoricoxib	1-(6-Methylpyridin-3-yl)-2-[4-(Methylsulfonyl)Phenyl] Ethanone [Ketosulfone] [221615-75-4], 2-Chloro-1,3-Bis(Dimethylamino) Trimethinium Hexafluoro Phosphate [249561-98-6]
Favipiravir	6-chloro-3-hydroxypyrazine-2-carbonitrile dicyclohexylamine salt [1137606-74-6]	DMF Available
Irbesartan	2-Butyl-1,3-Diazaspiro-[4,4]Non-1-en-4-one hydrochloride (Spiro) [151257-01-1]
Minoxidil	-
Modafinil	-
Naftidrofuryl Oxalate	1-(tetrahydro-2-furyl)-3-(1-naphthyl) propane-2-carboxylic acid (60% in toluene) [5379-26-4]	DMF Available	CEP Filing
Nebivolol HCl	ISOMER A [793669-26-8], ISOMER B [876514-31-7]	DMF Available	CEP Filing
Ornidazole	-	DMF Available
Rasagiline Mesylate	1-Aminoindane HCl [70146-15-5], (R)-(-)-1-Aminoindane HCl [10305-73-4]	DMF Available	KDMF/JDMF Filing
Solifenacin Succinate	3-Quinuclidinone HCl [1193-65-3], R-(-)-3-Quinuclidinol [25333-42-0], S-1-Phenyl 1,2,3,4 tetrahydro isoquinoline [118864-75-8]	DMF Available
Sumatriptan Succinate	4-Hydrazino-n-methane benzene methane sulphonamide HCl [88933-16-8], Sumatriptan Base [103628-46-2]	DMF Available	CEP/KDMF/ANVISA Filing
Tadalafil	(1R,3R)-Methyl 1-(benzo[d][1,3]dioxol-5-yl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylate hydrochloride [171752-68-4]	DMF Available
Tamsulosin	Tamsulosin Base [106133-20-4]
Telmisartan	2-n-Propyl-4-methyl-6-(1-methylbenzimidazole-2-yl) benzimidazole [152628-02-9]
Ticagrelor	4,6-Dichloro-2-propylthiopyrimidine-5-amine [145783-15-9]	DMF Available
Torsemide	-
Trazodone	1-(3-chlorophenyl)-4-(3-chloropropyl)-Piperazine [52605-52-4], 1,2,4-Triazolo-[4,3-a]pyridine-3(2H)-one [6969-71-7]	DMF Available	ANVISA Filing
Vardenafil	-
Voriconazole	-	DMF Available
Zaltoprofen	5-(1-Carboxyethyl)-2-(phenylthio)phenylacetic acid [83237-49-4]		JDMF/KDMF Filing

	Key Intermediates	DMF Status	Filing
Minoxidil	-
Modafinil	-
Ornidazole	-	DMF Available
Torsemide
Vardenafil
Voriconazole	-	DMF Available
Tadalafil	(1R,3R)-Methyl 1-(benzo[d][1,3]dioxol-5-yl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylate hydrochloride [171752-68-4]	DMF Available
Brivaracetam	(R)-4-Propyldihydrofuran-2(3H)-one [63095-51-2]
Trazodone	1-(3-chlorophenyl)-4-(3-chloropropyl)-Piperazine [52605-52-4], 1,2,4-Triazolo-[4,3-a]pyridine-3(2H)-one [6969-71-7]	DMF Available	ANVISA Filing
Etoricoxib	1-(6-Methylpyridin-3-yl)-2-[4-(Methylsulfonyl)Phenyl] Ethanone [Ketosulfone] [221615-75-4], 2-Chloro-1,3-Bis(Dimethylamino) Trimethinium Hexafluoro Phosphate [249561-98-6]
Naftidrofuryl Oxalate	1-(tetrahydro-2-furyl)-3-(1-naphthyl) propane-2-carboxylic acid (60% in toluene) [5379-26-4]	DMF Available	CEP Filing
Rasagiline Mesylate	1-Aminoindane HCl [70146-15-5], (R)-(-)-1-Aminoindane HCl [10305-73-4]	DMF Available	KDMF/JDMF Filing
Irbesartan	2-Butyl-1,3-Diazaspiro-[4,4]Non-1-en-4-one hydrochloride (Spiro) [151257-01-1]
Azilsartan Medoxomil Potassium Salt	2-ethoxy-1-{[2'-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)-1,1'-biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylic acid, [147403-03-0], Azilsartan Base	DMF Available	KDMF Filing
Telmisartan	2-n-Propyl-4-methyl-6-(1-methylbenzimidazole-2-yl) benzimidazole [152628-02-9]
Dapoxetine HCl	3-(Napthalen-1-yloxy)-1-phenylpropan-1-ol [908291-72-5], Dapoxetine Base [119356-77-3]	DMF Available
Benazepril HCl	3-Bromo-2,3,4,5-tetrahydro-2-h-1-benzacepin-2one [86499-96-9], tert-Butyl (S)-2-(3-amino-2-oxo-2,3,4,5-tetrahydro-1H-benzo[b]azepin-1-yl)acetate [109010-60-8]
Solifenacin Succinate	3-Quinuclidinone HCl [1193-65-3], R-(-)-3-Quinuclidinol [25333-42-0], S-1-Phenyl 1,2,3,4 tetrahydro isoquinoline [118864-75-8]	DMF Available
Ticagrelor	4,6-Dichloro-2-propylthiopyrimidine-5-amine [145783-15-9]	DMF Available
Darolutamide Intermediates	4-Bromo-2-Chlorobenzonitrile
Sumatriptan Succinate	4-Hydrazino-n-methane benzene methane sulphonamide HCl [88933-16-8], Sumatriptan Base [103628-46-2]	DMF Available	CEP/KDMF/ANVISA Filing
Zaltoprofen	5-(1-Carboxyethyl)-2-(phenylthio)phenylacetic acid [83237-49-4]		JDMF/KDMF Filing
Favipiravir	6-chloro-3-hydroxypyrazine-2-carbonitrile dicyclohexylamine salt [1137606-74-6]	DMF Available
Cabergoline Intermediates	Cabergoline Acid
Dabigatran Etexilate Mesylate	Ethyl 3-(3-amino-4-(methylamino)-N-(pyridin-2-yl)benzamido)propanoate [212322-56-0]	DMF Available	CEP Filing
Nebivolol HCl	ISOMER A [793669-26-8], ISOMER B [876514-31-7]	DMF Available	CEP Filing
Tamsulosin	Tamsulosin Base [106133-20-4]

	Key Intermediates	DMF Status	Filing
Benazepril HCl	3-Bromo-2,3,4,5-tetrahydro-2-h-1-benzacepin-2one [86499-96-9], tert-Butyl (S)-2-(3-amino-2-oxo-2,3,4,5-tetrahydro-1H-benzo[b]azepin-1-yl)acetate [109010-60-8]
Brivaracetam	(R)-4-Propyldihydrofuran-2(3H)-one [63095-51-2]
Cabergoline Intermediates	Cabergoline Acid
Darolutamide Intermediates	4-Bromo-2-Chlorobenzonitrile
Etoricoxib	1-(6-Methylpyridin-3-yl)-2-[4-(Methylsulfonyl)Phenyl] Ethanone [Ketosulfone] [221615-75-4], 2-Chloro-1,3-Bis(Dimethylamino) Trimethinium Hexafluoro Phosphate [249561-98-6]
Irbesartan	2-Butyl-1,3-Diazaspiro-[4,4]Non-1-en-4-one hydrochloride (Spiro) [151257-01-1]
Minoxidil	-
Modafinil	-
Tamsulosin	Tamsulosin Base [106133-20-4]
Telmisartan	2-n-Propyl-4-methyl-6-(1-methylbenzimidazole-2-yl) benzimidazole [152628-02-9]
Torsemide	-
Vardenafil	-
Zaltoprofen	5-(1-Carboxyethyl)-2-(phenylthio)phenylacetic acid [83237-49-4]		JDMF/KDMF Filing
Dabigatran Etexilate Mesylate	Ethyl 3-(3-amino-4-(methylamino)-N-(pyridin-2-yl)benzamido)propanoate [212322-56-0]	DMF Available	CEP Filing
Dapoxetine HCl	3-(Napthalen-1-yloxy)-1-phenylpropan-1-ol [908291-72-5], Dapoxetine Base [119356-77-3]	DMF Available
Favipiravir	6-chloro-3-hydroxypyrazine-2-carbonitrile dicyclohexylamine salt [1137606-74-6]	DMF Available
Naftidrofuryl Oxalate	1-(tetrahydro-2-furyl)-3-(1-naphthyl) propane-2-carboxylic acid (60% in toluene) [5379-26-4]	DMF Available	CEP Filing
Nebivolol HCl	ISOMER A [793669-26-8], ISOMER B [876514-31-7]	DMF Available	CEP Filing
Ornidazole	-	DMF Available
Rasagiline Mesylate	1-Aminoindane HCl [70146-15-5], (R)-(-)-1-Aminoindane HCl [10305-73-4]	DMF Available	KDMF/JDMF Filing
Solifenacin Succinate	3-Quinuclidinone HCl [1193-65-3], R-(-)-3-Quinuclidinol [25333-42-0], S-1-Phenyl 1,2,3,4 tetrahydro isoquinoline [118864-75-8]	DMF Available
Sumatriptan Succinate	4-Hydrazino-n-methane benzene methane sulphonamide HCl [88933-16-8], Sumatriptan Base [103628-46-2]	DMF Available	CEP/KDMF/ANVISA Filing
Tadalafil	(1R,3R)-Methyl 1-(benzo[d][1,3]dioxol-5-yl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylate hydrochloride [171752-68-4]	DMF Available
Ticagrelor	4,6-Dichloro-2-propylthiopyrimidine-5-amine [145783-15-9]	DMF Available
Trazodone	1-(3-chlorophenyl)-4-(3-chloropropyl)-Piperazine [52605-52-4], 1,2,4-Triazolo-[4,3-a]pyridine-3(2H)-one [6969-71-7]	DMF Available	ANVISA Filing
Voriconazole	-	DMF Available
Azilsartan Medoxomil Potassium Salt	2-ethoxy-1-{[2'-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)-1,1'-biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylic acid, [147403-03-0], Azilsartan Base	DMF Available	KDMF Filing

	Key Intermediates	DMF Status	Filing
Benazepril HCl	3-Bromo-2,3,4,5-tetrahydro-2-h-1-benzacepin-2one [86499-96-9], tert-Butyl (S)-2-(3-amino-2-oxo-2,3,4,5-tetrahydro-1H-benzo[b]azepin-1-yl)acetate [109010-60-8]
Brivaracetam	(R)-4-Propyldihydrofuran-2(3H)-one [63095-51-2]
Cabergoline Intermediates	Cabergoline Acid
Dapoxetine HCl	3-(Napthalen-1-yloxy)-1-phenylpropan-1-ol [908291-72-5], Dapoxetine Base [119356-77-3]	DMF Available
Darolutamide Intermediates	4-Bromo-2-Chlorobenzonitrile
Etoricoxib	1-(6-Methylpyridin-3-yl)-2-[4-(Methylsulfonyl)Phenyl] Ethanone [Ketosulfone] [221615-75-4], 2-Chloro-1,3-Bis(Dimethylamino) Trimethinium Hexafluoro Phosphate [249561-98-6]
Favipiravir	6-chloro-3-hydroxypyrazine-2-carbonitrile dicyclohexylamine salt [1137606-74-6]	DMF Available
Irbesartan	2-Butyl-1,3-Diazaspiro-[4,4]Non-1-en-4-one hydrochloride (Spiro) [151257-01-1]
Minoxidil	-
Modafinil	-
Ornidazole	-	DMF Available
Solifenacin Succinate	3-Quinuclidinone HCl [1193-65-3], R-(-)-3-Quinuclidinol [25333-42-0], S-1-Phenyl 1,2,3,4 tetrahydro isoquinoline [118864-75-8]	DMF Available
Tadalafil	(1R,3R)-Methyl 1-(benzo[d][1,3]dioxol-5-yl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylate hydrochloride [171752-68-4]	DMF Available
Tamsulosin	Tamsulosin Base [106133-20-4]
Telmisartan	2-n-Propyl-4-methyl-6-(1-methylbenzimidazole-2-yl) benzimidazole [152628-02-9]
Ticagrelor	4,6-Dichloro-2-propylthiopyrimidine-5-amine [145783-15-9]	DMF Available
Torsemide	-
Vardenafil	-
Voriconazole	-	DMF Available
Trazodone	1-(3-chlorophenyl)-4-(3-chloropropyl)-Piperazine [52605-52-4], 1,2,4-Triazolo-[4,3-a]pyridine-3(2H)-one [6969-71-7]	DMF Available	ANVISA Filing
Dabigatran Etexilate Mesylate	Ethyl 3-(3-amino-4-(methylamino)-N-(pyridin-2-yl)benzamido)propanoate [212322-56-0]	DMF Available	CEP Filing
Naftidrofuryl Oxalate	1-(tetrahydro-2-furyl)-3-(1-naphthyl) propane-2-carboxylic acid (60% in toluene) [5379-26-4]	DMF Available	CEP Filing
Nebivolol HCl	ISOMER A [793669-26-8], ISOMER B [876514-31-7]	DMF Available	CEP Filing
Sumatriptan Succinate	4-Hydrazino-n-methane benzene methane sulphonamide HCl [88933-16-8], Sumatriptan Base [103628-46-2]	DMF Available	CEP/KDMF/ANVISA Filing
Zaltoprofen	5-(1-Carboxyethyl)-2-(phenylthio)phenylacetic acid [83237-49-4]		JDMF/KDMF Filing
Azilsartan Medoxomil Potassium Salt	2-ethoxy-1-{[2'-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)-1,1'-biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylic acid, [147403-03-0], Azilsartan Base	DMF Available	KDMF Filing
Rasagiline Mesylate	1-Aminoindane HCl [70146-15-5], (R)-(-)-1-Aminoindane HCl [10305-73-4]	DMF Available	KDMF/JDMF Filing

Innovation as a Driving Force

At Maithili Life Sciences, we don’t just follow industry trends; we set them. Our state-of-the-art research and development facilities are hubs of innovation, constantly pushing the boundaries of pharmaceutical science. By investing in cutting-edge technologies, we deliver not just products but solutions that anticipate and meet the evolving demands of the industry.

Sustainability at the Core of Our Practices

We recognize the responsibility that comes with our role in healthcare. Sustainability is not just a buzzword for us; it’s a commitment embedded in our practices. From eco-friendly manufacturing processes to ethical sourcing, we prioritize environmental responsibility. Partnering with Maithili Life Sciences means aligning with a company that cares not only about your success but also the well-being of our planet.

Why Choose Maithili Life Sciences for your API and Intermediates?

Global Reputation

With a strong presence in the international pharmaceutical landscape, Maithili Life Sciences is your global partner in healthcare advancement.

Quality Assurance

Our APIs and Intermediates undergo stringent quality control measures, ensuring a consistent and reliable supply for your manufacturing needs.

Collaborative Approach

We believe in collaborative success. Your goals become ours, and together, we drive innovation and excellence in pharmaceutical manufacturing.

Contact Us for a Transformative Partnership

Embark on a transformative journey with Maithili Life Sciences. Whether you seek high-quality APIs, intermediates, or a strategic collaboration, we invite you to explore the possibilities with us. Reach out to our team today, and let’s shape the future of healthcare together.

Kindly Note

Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer’s risk.